Literature DB >> 2224772

DNA analysis of multiple synchronous renal cell carcinomas.

B F Banner1, L Brancazio, R R Bahnson, M S Ernstoff, S R Taylor.   

Abstract

The authors used retrospective quantitative DNA analysis to study interrelationships between multiple synchronous renal cell carcinomas in seven patients. DNA content was determined by image analysis on Feulgen-stained nuclear smears prepared from multiple paraffin blocks from each tumor. Tumors were unilateral in four cases and bilateral in three. Ten tumors had homogeneous, and four heterogeneous DNA stemlines. Intertumoral heterogeneity in four cases suggested multifocal origin. Identical DNA aneuploid indices in bilateral tumors in one case suggested metastasis from a solitary origin. Abnormal DNA content and heterogeneous populations began to appear in the size range 2.0 to 5.0 cm. All tumors over 5.0 cm contained nondiploid populations. Although the interrelationships between these multiple synchronous neoplasms are not entirely clear, the DNA analysis suggests that the occurrence of nondiploid stemlines and heterogeneous DNA content may parallel both tumor growth and more aggressive behavior.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2224772     DOI: 10.1002/1097-0142(19901115)66:10<2180::aid-cncr2820661023>3.0.co;2-i

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Heterogeneity and progression of renal cell carcinomas as revealed by DNA cytofluorometry and the significance of the presence of polyploid cells.

Authors:  M Kushima; R Kushima; T Hattori; T Tomoyoshi
Journal:  Urol Res       Date:  1995

2.  Synchronous primary lung cancers: prevalence in surgical material and clinical implications.

Authors:  F A Carey; S C Donnelly; W S Walker; E W Cameron; D Lamb
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

3.  Nuclear morphometry and DNA densitometry of human gliomas by image analysis.

Authors:  Y Yoshii; A Saito; T Nose
Journal:  J Neurooncol       Date:  1995-10       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.